Literature DB >> 28476802

Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.

Kuniaki Sato1,2, Takaaki Masuda1, Qingjiang Hu1, Taro Tobo3, Shinya Kidogami1, Yushi Ogawa1, Tomoko Saito1, Sho Nambara1, Hisateru Komatsu1, Hidenari Hirata1, Shotaro Sakimura1, Ryutaro Uchi2, Naoki Hayashi1, Tomohiro Iguchi1, Hidetoshi Eguchi1, Shuhei Ito1, Takashi Nakagawa2, Koshi Mimori4.   

Abstract

BACKGROUND/AIM: Amplification of chromosome 7p (Ch.7p) is common in colorectal cancer (CRC). The aim of this study was to identify potential driver genes on Ch.7p that are overexpressed due to DNA copy number amplification and determine their clinical significance in CRC.
MATERIALS AND METHODS: We identified phosphoserine phosphatase (PSPH) as a potential driver gene using a CRC dataset from The Cancer Genome Atlas (TCGA) using a bioinformatics approach. The expression of PSPH in 124 primary CRCs was examined by quantitative reverse transcription polymerase chain reaction (PCR) and immunohistochemistry. The biological effect of PSPH expression was explored by Gene Set Enrichment Analysis (GSEA) using the TCGA dataset.
RESULTS: PSPH was overexpressed in tumor tissues and PSPH positively correlated with depth of invasion and distant metastasis. On multivariate analysis, high PSPH expression was an independent poor prognostic factor. These results were supported by GSEA.
CONCLUSION: PSPH could be a novel prognostic biomarker with malignant potential on Ch.7p in CRC. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  PSPH; colorectal cancer; intra-tumor heterogeneity; prognostic biomarker

Mesh:

Substances:

Year:  2017        PMID: 28476802     DOI: 10.21873/anticanres.11574

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.

Authors:  Wenfei Li; Min Fu; Kun Zhao; Fang Han; Ning Bu; Zhanqiu Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-27       Impact factor: 2.503

2.  Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.

Authors:  Muthana Al Abo; Terry Hyslop; Xiaodi Qin; Kouros Owzar; Daniel J George; Steven R Patierno; Jennifer A Freedman
Journal:  Genomics       Date:  2021-03-08       Impact factor: 5.736

3.  Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.

Authors:  Yuta Kouyama; Takaaki Masuda; Atsushi Fujii; Yushi Ogawa; Kuniaki Sato; Taro Tobo; Hiroaki Wakiyama; Yukihiro Yoshikawa; Miwa Noda; Yusuke Tsuruda; Yousuke Kuroda; Hidetoshi Eguchi; Fumio Ishida; Shin-Ei Kudo; Koshi Mimori
Journal:  Cancer Sci       Date:  2019-08-29       Impact factor: 6.716

Review 4.  The Roles of Transmembrane Mucins Located on Chromosome 7q22.1 in Colorectal Cancer.

Authors:  Hussain Almasmoum
Journal:  Cancer Manag Res       Date:  2021-04-14       Impact factor: 3.989

5.  PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1.

Authors:  Vipin Rawat; Parmanand Malvi; Deborah Della Manna; Eddy S Yang; Suresh Bugide; Xuchen Zhang; Romi Gupta; Narendra Wajapeyee
Journal:  Oncogene       Date:  2021-03-05       Impact factor: 8.756

6.  GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein.

Authors:  Kensuke Koike; Takaaki Masuda; Kuniaki Sato; Atsushi Fujii; Hiroaki Wakiyama; Taro Tobo; Junichi Takahashi; Yushi Motomura; Takafumi Nakano; Hideyuki Saito; Yoshihiro Matsumoto; Hajime Otsu; Kazuki Takeishi; Yusuke Yonemura; Koshi Mimori; Takashi Nakagawa
Journal:  Cancer Sci       Date:  2021-11-10       Impact factor: 6.716

7.  Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells.

Authors:  Ma-Yan Huang; Xiao-Yun Liu; Qiong Shao; Xu Zhang; Lei Miao; Xiao-Yan Wu; Yu-Xia Xu; Fang Wang; Hai-Yun Wang; Liang Zeng; Ling Deng
Journal:  BMC Gastroenterol       Date:  2022-01-03       Impact factor: 3.067

8.  PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways.

Authors:  Li Liao; Mengxi Ge; Qiong Zhan; Ruofan Huang; Xiaoyu Ji; Xiaohua Liang; Xinli Zhou
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

9.  GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.

Authors:  Sho Nambara; Takaaki Masuda; Yuta Kobayashi; Kuniaki Sato; Taro Tobo; Kensuke Koike; Miwa Noda; Yushi Ogawa; Yousuke Kuroda; Shuhei Ito; Hidetoshi Eguchi; Keishi Sugimachi; Koshi Mimori
Journal:  Cancer Sci       Date:  2019-12-27       Impact factor: 6.716

10.  Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.

Authors:  Yue Yu; Zhihua Li; Chenjun Huang; Haisheng Fang; Fei Zhao; Yue Zhou; Xianglong Pan; Qifan Li; Yu Zhuang; Liang Chen; Jing Xu; Wei Wang
Journal:  Cancer Med       Date:  2019-12-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.